- 全部删除
- 您的购物车当前为空
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate(CDC)是一种强效 12/15-脂氧合酶(12/15-LO)抑制剂(IC50 = 9-25nm),可用于 1 型糖尿病研究。
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate(CDC)是一种强效 12/15-脂氧合酶(12/15-LO)抑制剂(IC50 = 9-25nm),可用于 1 型糖尿病研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 598 | In stock | |
5 mg | ¥ 987 | 6-8周 | |
10 mg | ¥ 1,550 | 6-8周 | |
100 mg | ¥ 6,990 | 6-8周 |
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate 相关产品
产品描述 | Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-lipoxygenase (12/15-LO) inhibitor (IC50 = 9-25nm), studied for type 1 diabetes. |
体外活性 | High glucose or 12(S)-HETE remarkably increased transendothelial dextran transport, and in combination it was increased further. Addition of the 12/15-LO inhibitor, CDC, partially suppressed dextran transport [1]. |
体内活性 | The high glucose and 12(S)-hydroxyeicosatetraenoic acid (HETE) could alter vascular endothelial (VE)-cadherin and β‐catenin phosphorylation levels, but did not alter total protein expression. However, the 12/15-LO inhibitor, Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC), antagonized the effect of high glucose on protein phosphorylation to mitigate destruction of the endothelial cell barrier, and the mouse diabetes mellitus model further confirmed these conclusions [1]. |
别名 | CDC, 3,4-二羟基-α-氰基肉桂酸肉桂基酯 |
分子量 | 321.33 |
分子式 | C19H15NO4 |
CAS No. | 132465-11-3 |
Smiles | Oc1ccc(\C=C(/C#N)C(=O)OC\C=C\c2ccccc2)cc1O |
存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 40 mg/mL (124.48 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容